Let's Connect

News

The MDD Pipeline: New Mechanisms Beyond the Monoamine Model

By Industry News 1 min read

​The field finally has new targets after decades anchored to monoamines. Dr. DeBattista explains why he welcomes them while predicting, from experience, that most of them will not work out.  — From Psychiatric Times articles Read More

Share this post
All News posts
News Industry News 11:30 am Updates on CTx-1301, NDA Resubmission After FDA Complete Response Letter ​Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests  — From Psychiatric Times articles Read More News Industry News 11:00 am New National Guidance for Managing Medetomidine Intoxication and Withdrawal ​The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.  — From Psychiatric Times articles Read More News Industry News 10:00 am Can Digital Memory Tests Detect Tau-Related Cognitive Change Before Alzheimer Disease? ​Digital memory tests flag subtle preclinical Alzheimer changes, especially with neocortical tau; scalable tools may boost future trial screening.  — From Psychiatric Times articles Read More

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.